Skip to Main Content
CWRU Links

School of
Medicine

Cancer Stem Cell Retreat

 

The 2017 Cancer Stem Cell retreat will be held June 16, 2017 at the Cleveland Clinic Lerner Research Institute (Room NE1-205), from 9:00 AM-6:00 PM. The goal of this upcoming retreat is to foster scientific discovery, facilitate local collaboration, bridge translational applications, and educate trainees. 

Cleveland Clinic Lerner Research Institute, Room NE1-205
9620 Carnegie Avenue
Cleveland, OH 44195
 

Driving Directions

CSC Retreat will feature:
  • Keynote presentation 
        Ronald J. Buckanovich, M.D., Ph.D.
         University of Michigan 
  • Industrial talks
  • Trainee presentations (selected from submitted abstracts)
  • Abstract awards
  • Networking lunch
  • Poster session and networking reception

Registration

There is no cost to attend this retreat. However, registration is required to access this event. To register, click here. Registration will close on June 14, 2017.

If you experience issues with registration, please email clm25@case.edu.


Retreat Abstracts

We would like to invite attendees to submit abstracts for the retreat. Top abstracts will be selected for trainee talks. The top three submitted abstracts will be awarded a prize. Abstracts should be 300-500 words (max).


Abstract Guidelines

Submission Deadline

The deadline for submitting abstracts was extended to June 9,2017. Please note, abstracts submitted past the original deadline (May 8th) will not be considered for an abstract award and/or trainee talk.

Notification of Acceptance

Individuals will be notified by May 26, 2017 if their submission was approved for a poster presentation. 

Email your abstract submission to clm25@case.edu.


Retreat Agenda

9:00 AM - 9:25 AM  Retreat Check-in & Breakfast
9:25 AM - 9:30 AM Welcome
  Session 1: Emerging Technologies
9:30 AM - 9:50 AM  Cancer stem cell characterization and targeting through phage display peptide screening
James Liu, MD

MetroHealth Medical System
9:50 AM - 10:10 AM NK Cell Therapy for Cancer
David Wald, MD, PhD

Case Western Reserve University
10:10 AM - 10:25 AM miRNA-sensor platform to delineate regulation of stem-like properties by miRNAs in cancers
Anil Belur Nagaraj, MBBS, PhD

Case Western Reserve University
10:25 AM - 10:40 AM Modeling glioblastoma through cancer stem cell organoids
Chris Hubert, PhD

Cleveland Clinic
10:40 AM -11:00 AM Coffee Break
  Session 2: Industrial Session
11:00 AM - 11:20 AM  Immune modulation with MultiStem® cell therapy
Sarah Busch, PhD

Athersys, Inc
11:20 AM - 11:40 AM Targeting by design: leverage a quality by design platform to identify points of fragility for cancer stem cell targeting
Jan Jensen, PhD

OH Alive
11:40 AM - 1:00 PM Lunch & Networking
1:00 PM - 2:00 PM Keynote Presentation

Revisiting the Cancer Stem Cell Hypothesis and Why it Matters
Ronald J. Buckanovich MD, PhD
Thomas H. Simpson Collegiate Professor
Department of Internal Medicine
Division of Hematology Oncology
Division of Gynecologic Oncology
University of Michigan
2:00 PM - 2:20 PM  Targeting kinesins to radiosensitize glioblastoma cancer stem cells
Monica Venere, PhD

The Ohio State University
2:20 PM - 2:40 PM  Effective targeting of GBM stem cells in the hypoxic microenvironment
Eli E. Bar, PhD

University Hospitals
2:40 PM - 2:55 PM Therapeutic targeting of GLI-code in hematopoietic malignancies
Metis Hasipek, PhD

Cleveland Clinic
2:55 PM - 3:10 PM Targeting Cx46-mediates cell-cell communication in glioblastoma
Luke Torre-Healy

Cleveland Clinic
3:10 PM - 3:30 PM Coffee Break
  Session 4: Novel CSC Regulatory Mechanisms
3:30 PM - 3:50 PM A new role for the membrane complement regulating protein CD55 in cancer stem cell self-renewal and cisplatin resistance
Ofer Reizes, PhD

Cleveland Clinic
3:50 PM - 4:10 PM A role for FABP5/PPARΔ pathway in maintenance of cancer stem cells
Liraz Levy, PhD

Case Western Reserve University
4:10 PM - 4:25 PM Elucidating the mechanism of dysregulation and efficacy of pharmacologically targeting the APC/C in glioblastoma
Kuntal De, PhD 

The Ohio State University
4:25 PM - 4:40 PM Cx26 drives self-renewal in triple-negative breast cancer via interaction with focal adhesion kinase and Nanog
Praveena Thiagarajan, MD, PhD

Cleveland Clinic
4:40 PM - 4:45 PM Closing Remarks
4:40 PM - 6:00 PM Poster Session & Networking Reception